In MDS, DNA methylation or DNA repair, chromatin modification, RNA splicing, signal transcription, and mucin regulation are the main mutational targets, and these mutational modalities share a common clonal origin with AML (20). Here, MUC5AC is linked to myelodysplastic syndrome.